IVAC-RCC-001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IVAC-RCC-001, covering 2024-09-19 to 2024-09-19. Get the full timeline:
Most recent: Clinical Trial Update: IVAC-RCC-001: A Personalized Neoantigen Vaccine as Add-on to Standard of Care Checkpoint Inhibitor in Advanced/Metastatic RCC Patients [Phase 1]